News & Analysis on Clinical Trial Services & Contract Research And Development
Bora Pharmaceuticals: acquisition of former GSK facility
By Jenni Spinner
- Last updated on
Bora Pharmaceuticals has completed acquisition of GSK’s Mississauga, Ontario (Canada) facility. The purchased site will become Bora’s first North American manufacturing facility and the new home to its North American headquarters.
According to the company, the purchase of the site will enable Bora to produce approximately 50 different products to 100 markets around the world. The terms of the transaction include a minimum five-year supply agreement with GSK.